Current remedies for jet lag (phototherapy, melatonin, stimulant, and sedative medications) are limited in efficacy and practicality. The efficacy of a stabilized, sublingual form of reduced nicotinamide adenine dinucleotide (NADH, ENADAlert®, Menuco Corp.) as a countermeasure for jet lag was … Continued
The supplement was tested by researchers at Georgetown University Medical Center, who found that people taking it experienced significant improvement in relieving the symptoms of fatigue. To read the study please click this link : Supplement Can Help Boost Energy … Continued
A DIETARY SUPPLEMENT MAY BENEFIT VICTIMS OF CHRONIC FATIGUE SYNDROME, researchers announced at a news conference here Tuesday. “We’ve demonstrated a real benefit with NADH in this study,” said Dr. Joseph A. Bellanti of the Georgetown University School of Medicine, … Continued
The coenzyme nicotinamide adenine dinucleotide (NADH) has been used in an open label trial as medication in 205 patients suffering from depression with various clinical symptoms. NADH was given orally, intramuscularly or intravenously. The duration of therapy ranged from 5 … Continued
Chronic fatigue syndrome (CFS) is a disorder of unknown etiology, consisting of prolonged, debilitating fatigue, and a multitude of symptoms including neurocognitive dysfunction, flu0like symptoms, myalgia, weakness, arthralgia, low-grade fever, sore throat, headache, sleep disturbances, and swelling and tenderness of … Continued
Click this link to view the entire study: Down Syndrome and Alzheimers The reduction of NADH ubiquinone oxidoreductase 24- and 75-kDa subunits in brains of patients with Down syndrome and Alzheimer’s disease. Kim SH, Vlkolinsky R, Cairns N, … Continued
NEW FOLLOW-UP STUDY SHOWS THAT A NATURALLY OCCURRING COENZYME NUTRITIONAL SUPPLEMENT ENADA® NADH CLINICALLY DEMONSTRATES BENEFITS FOR ALZHEIMER’S PATIENTS To read the study please click this link : Nov 2002 ICMAN Study on Alzheimers 2nd International Conference on Mechanisms and … Continued
Objective: To evaluate the effect of stabilized oral NADH (reduced nicotinamide adenine dinucleotide; ENADA®) on cognitive functioning in patients with AD. To read the study please click this link : 2002 Treatment of Alzheimers Double Blind Study Treatment of … Continued
Summary: This study was designed to evaluate the effect of stabilized oral reduced nicotinam,de adenine din ucleotide (NADH) on cognitive functioning in patients with Alzheimer’s dsease (AD). NADHis a coenzyme that plays a key role in cellular energy production and … Continued
Although significant progress has been achieved in revealing the etiology of AD, the search for efficient therapy stays the man goal. Nicotinamide adenine dinucleotide (NADH) is biologically identified as a cofactor necessary for a number of cellular actions, such as … Continued